TriSalus Life Science’s drug delivery shows efficacy against pancreatic cancer
WESTMINSTER -- A phase 1b clinical trial shows that administering a concentrated dose of anti-CEA CAR-T cells precisely at the site of a solid tumor by means of TriSalusLife Sciences unique... Read More
Wednesday November 7, 2018 0 comments
TriSalus Life Sciences names Daniel Estay chief business officer
DENVER -- TriSalus Life Sciences announced the appointment of Daniel Estay as its chief business officer, reporting to the companys chief executive officer, Mary Szela . TriSalus (formerly... Read More
Monday September 24, 2018 0 comments
Surefire Medical study: Surefire Infusion improves liver cancer treatment
WESTMINSTER -- Surefire Medical, developer of site-specific delivery devices for the interventional oncology market, announced results from a retrospective analysis of 85 bridge-to-transplant... Read More
Friday June 9, 2017 0 comments
Surefire Medical closes on $12.8M Series D funding
WESTMINSTER -- Surefire Medical, Inc. , developer of site-specific delivery devices for the interventional oncology market, announced the first closing ofa $12.8 million Series D financing round.... Read More
Friday March 10, 2017 0 comments
Surefire Medical reaches critical commercialization milestone in Germany
WESTMINSTER -- Surefire Medical, Inc. today announced the German Institute of Medical Documentation and Information (DIMDI) has issued a unique classification code (OPS) for the Surefire... Read More
Monday September 12, 2016 0 comments
.jpg)
CBSA: 2015 was groundbreaking year for life sciences industry
DENVER -- Colorados life sciences sector had a robust and groundbreaking 2015, according to the Colorado BioScience Association (CBSA), the states advocate for the industry. CBSA reported... Read More
Wednesday December 16, 2015 0 comments
Surefire Medical closes $15M Series C funding for Surefire Precision
WESTMINSTER -- Surefire Medical Inc. , a commercial-stage company developing a new class of direct-to-tumor delivery systems used in minimally invasive interventional procedures, announced the... Read More
Thursday December 3, 2015 0 comments
Surefire Medical launches Precision liver tumor drug delivery infusion system
WESTMINSTER -- Surefire Medical Inc . today announced the launch of its new Precision targeted delivery infusion system for direct-to-tumor embolization procedures. The new technology will be... Read More
Friday September 25, 2015 0 comments
IN Sponsors
Browse
Entrepreneurial by Nature
